BZAD-01
Product Specifications
UNSPSC Description
BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation[1].
Target Antigen
iGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel;Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bzad-01.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic)|Methanol : 250 mg/mL (ultrasonic)
Smiles
N=C(NCC1=C(C(F)(F)F)C=CC=C1)C2=CC=C(C=C2)OC(F)(F)F
Molecular Weight
362.27
References & Citations
[1]Truong L, et, al. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions. Brain Res Bull. 2009 Feb 16;78(2-3):91-6.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-121100/BZAD-01-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-121100/BZAD-01-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
305339-41-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1108952-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O45:K1 2-keto-3-deoxy-L-rhamnonate aldolase (rhmA)
Ask
View Details 
MBS1108952-02 0.02 mg (Yeast)
Recombinant Escherichia coli O45:K1 2-keto-3-deoxy-L-rhamnonate aldolase (rhmA)
Ask
View Details MBS1108952-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O45:K1 2-keto-3-deoxy-L-rhamnonate aldolase (rhmA)
Ask
View Details